About: Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. Further, it operates laboratories. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.
Sector: Healthcare
Industry: Diagnostics & Research
Latest price: $24.09 (+5.38%)
BDSX NASDAQ Biodesix Inc
Biodesix Inc share price
Atividade de preço de BDSX
Último preço
$ 24,090
Variação (24h)
1,23 USD (5,38%)
Volume
24.35K
Volume (média 4 sem.)
-
Abertura
$ 23,24
Variação do dia
$ 22,94 - $ 24,37
Fechamento anterior
$ 22,86
Último negócio
29 Oct, 3:30 pm GMT+0
Atrasado
29 Oct, 3:30 pm GMT+0
BDSX price performance
Atrasado
29 Oct, 3:30 pm GMT+0
quote.marketSignals